Literature DB >> 10516605

Biosafety considerations for flow cytometric analysis of human immunodeficiency virus-infected samples.

I Schmid1, A Kunkl, J K Nicholson.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10516605     DOI: 10.1002/(sici)1097-0320(19991015)38:5<195::aid-cyto1>3.0.co;2-p

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


× No keyword cloud information.
  5 in total

Review 1.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  International Society for the Advancement of Cytometry cell sorter biosafety standards.

Authors:  Kevin L Holmes; Benjamin Fontes; Philip Hogarth; Richard Konz; Simon Monard; Charles H Pletcher; Robert B Wadley; Ingrid Schmid; Stephen P Perfetto
Journal:  Cytometry A       Date:  2014-03-13       Impact factor: 4.355

3.  Standard practice for cell sorting in a BSL-3 facility.

Authors:  Stephen P Perfetto; David R Ambrozak; Richard Nguyen; Mario Roederer; Richard A Koup; Kevin L Holmes
Journal:  Methods Mol Biol       Date:  2011

4.  Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.

Authors:  David van Bockel; David A Price; Tedi E Asher; Vanessa Venturi; Kazuo Suzuki; Kristina Warton; Miles P Davenport; David A Cooper; Daniel C Douek; Anthony D Kelleher
Journal:  J Immunol Methods       Date:  2007-08-09       Impact factor: 2.303

Review 5.  Biosafety during a pandemic: shared resource laboratories rise to the challenge.

Authors:  Avrill M Aspland; Iyadh Douagi; Andrew Filby; Evan R Jellison; Lola Martinez; Diana Shinko; Adrian L Smith; Vera A Tang; Sherry Thornton
Journal:  Cytometry A       Date:  2021-01-04       Impact factor: 4.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.